Aurobindo Pharma announced on Thursday that its board has approved a buyback of 51.37 lakh shares at Rs 1,460 per share, marking a 6.4% premium over Tuesday's closing price. The record date for the Rs 750 crore share buyback scheme, conducted via the tender offer route, is set for July 30.
